Since the COVID-19 pandemic began, we have taken important steps to deliver timely accommodations to providers and customers, helping to ensure that customers have continued access to COVID-19 screening, testing, and treatment in safe settings.
Accordingly, to align with the recent extension of the federal public health emergency (PHE) period, we are again extending the cost-share waiver for COVID-19 testing and testing-related services through April 20, 2021
In Addition, for Home Health Services, eviCore will replace CareCentrix. February 1, 2021, eviCore healthcare (eviCore), a Cigna company, will begin managing home health, durable medical equipment (DME), home infusion therapy, and sleep diagnostic services for Cigna commercial customers. CareCentrix will not approve orders for these services after January 31.
For home services beginning on or after February 1, contact participating providers directly.
Note, however, that the process for ordering sleep diagnostic services for your patients with Cigna coverage is not changing; continue to send these orders to a participating provider.
The January Cigna Network News is also provided in the below attachments.
Please read all of the attachments for further details.
